Related Experiment Video
Updated: Jul 5, 2026
![Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F58641.jpg&w=3840&q=50)
Semi-quantitative Assessment Using [18F]FDG Tracer in Patients with Severe Brain Injury
Published on: November 9, 2018
Quantitative techniques in 18FDG PET scanning in oncology
1Department of Radiotherapy, Royal Marsden NHS Foundation Trust, Downs Road, Sutton SM2 5PT, UK.
Positron emission tomography (PET) with (18)F-fluoro-2-deoxyglucose ((18)FDG) is crucial in oncology. Advanced quantitative analysis of radiopharmaceutical kinetics is increasingly needed for clinical trials monitoring treatment response.
Area of Science:
- Oncology
- Nuclear Medicine
- Radiochemistry
Background:
- Established clinical applications of (18)F-fluoro-2-deoxyglucose ((18)FDG) positron emission tomography (PET) in oncology.
- Routine clinical examinations often utilize simple static PET scanning.
- Increasing use of PET in clinical trials necessitates advanced analysis for novel tracers and treatment response monitoring.
Purpose of the Study:
- To review various PET analysis techniques for clinical trials.
- To focus on methodologies for quantitative analysis of radiopharmaceutical kinetics.
- To highlight methods suitable for monitoring treatment response in oncology clinical trials.
Main Methods:
- Discussion of a range of PET analysis techniques.
- Inclusion of visual analysis and semiquantitative methods.
- Emphasis on dynamic studies with kinetic analysis for quantitative insights.
Main Results:
- PET analysis techniques vary from simple visual to complex kinetic modeling.
- Quantitative analysis of radiopharmaceutical kinetics is essential for clinical trials.
- Methodologies discussed are applicable to monitoring treatment response.
Conclusions:
- A spectrum of PET analysis methods exists, from basic to advanced kinetic modeling.
- Quantitative kinetic analysis of PET tracers is vital for evaluating treatment efficacy in clinical trials.
- The discussed methodologies support the use of PET in oncology clinical trials for precise treatment response assessment.
More Related Videos
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
10:02Quantification of Atherosclerotic Plaque Activity and Vascular Inflammation using [18-F] Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG-PET/CT)
Published on: May 2, 2012
Related Concept Videos
Imaging Studies II: Positron Emission Tomography and Scintigraphy
Fundamental Principles of PET
Positron Emission Tomography
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body being...
Radiological Investigation III: Pulmonary Angiogram and PET Scan
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...